SELLAS Advances Blood Cancer Treatment with “Tremendous Therapeutic Promise”
October 11, 2023
October 11, 2023 SELLAS Life Sciences Group, Inc. (Nasdaq: SLS) has reported two significant milestones this week as it pursues development of its drug candidate,